| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Cyclin-D1-binding protein 1, Grap2 and cyclin-D-interacting protein, Human homolog of Maid, CCNDBP1, DIP1, GCIP, HHM |
| Entrez GeneID | 23582 |
| WB Predicted band size | 40.3kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This CCNDBP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-49 amino acids from the N-terminal region of human CCNDBP1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于CCNDBP1(N-term)抗体的模拟参考文献示例(请注意，部分内容可能基于假设，实际文献需通过学术数据库验证)：
---
1. **文献名称**: "CCNDBP1 suppresses tumor progression by inhibiting cyclin D1 degradation in hepatocellular carcinoma"
**作者**: Li, X., et al.
**摘要**: 本研究利用CCNDBP1(N-term)抗体通过Western blot和免疫组化分析肝癌组织中的蛋白表达，发现CCNDBP1通过稳定Cyclin D1抑制肿瘤生长，其低表达与患者预后不良相关。
2. **文献名称**: "Characterization of CCNDBP1 interaction with cell cycle regulators using a novel N-terminal specific antibody"
**作者**: Zhang, Y., et al.
**摘要**: 作者开发并验证了一种CCNDBP1(N-term)抗体，通过免疫共沉淀(Co-IP)和免疫荧光证实其特异性，揭示了CCNDBP1与Cyclin D1及CDK4的相互作用机制。
3. **文献名称**: "CCNDBP1 as a potential biomarker in breast cancer: Insights from antibody-based profiling"
**作者**: Wang, H., et al.
**摘要**: 该研究使用CCNDBP1(N-term)抗体对乳腺癌组织芯片进行染色，发现CCNDBP1在ER阳性样本中高表达，且与化疗敏感性相关，提示其作为治疗靶点的潜力。
4. **文献名称**: "Technical validation of a polyclonal CCNDBP1(N-term) antibody for immunohistochemistry and flow cytometry"
**作者**: Abcam Technical Report (2017)
**摘要**: 该技术报告详细验证了CCNDBP1(N-term)抗体在多种实验中的应用条件，包括抗原修复优化及交叉反应性测试，确认其在人/小鼠组织中的特异性。
---
**建议**：实际文献可通过PubMed或Google Scholar搜索关键词“CCNDBP1 antibody N-term”或“CCNDBP1 AND (antibody validation)”获取，并优先选择近5年研究以更新数据。
CCNDBP1 (N-term) antibody is designed to target the N-terminal region of the Cyclin D1-Binding Protein 1 (CCNDBP1), also known as DIP1 or MGC75871. CCNDBP1 is a nuclear and mitochondrial protein implicated in transcriptional regulation and cell cycle control. It interacts with Cyclin D1. a key regulator of G1/S phase transition, and acts as a transcriptional repressor, modulating cell proliferation and differentiation. Structurally, CCNDBP1 contains a helix-loop-helix domain critical for protein interactions and DNA binding. The N-terminal region, recognized by this antibody, includes functional motifs that mediate its role in transcriptional regulation and signaling pathways, such as TGF-β and p53.
Studies suggest CCNDBP1 may function as a tumor suppressor, with reduced expression observed in cancers like hepatocellular carcinoma and breast cancer. Its downregulation correlates with enhanced cell cycle progression, metastasis, and poor prognosis. The CCNDBP1 (N-term) antibody is widely used in research applications, including Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP), to investigate its expression, localization, and molecular interactions. This antibody aids in elucidating CCNDBP1's role in cell cycle dynamics, apoptosis, and cancer biology, providing insights into therapeutic strategies targeting cell cycle dysregulation.
×
